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Abstract To study Bax-induced release of cytochrome c in vivo,
we have expressed a cytochrome c^GFP (green fluorescent
protein) fusion in Saccharomyces cerevisiae cells null for the
expression of the endogenous cytochrome. We show here that
cytochrome c^GFP is efficiently localised to mitochondria and
able to function as an electron carrier between complexes III and
IV of the respiratory chain. Strikingly, while natural cytochrome
c is released into the cytoplasm upon expression of Bax, the
cytochrome c^GFP fusion is not. Nevertheless, cells co-expres-
sing Bax and the cytochrome c^GFP fusion die, indicating that
mitochondrial release of cytochrome c is not essential for cell
death to occur in yeast. The failure to release cytochrome c^GFP
is presumed to arise from increased bulk due to the GFP moiety.
We propose that in intact yeast cells, Bax-induced release of
cytochrome c into the cytoplasm occurs through a selective pore
and not as a consequence of the non-specific breakage of the
mitochondrial outer membrane.
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1. Introduction
Because they release apoptogenic factors, mitochondria
play a key role during programmed cell death in multicellular
organisms [1]. Cytochrome c was the ¢rst mitochondrial apop-
togenic protein identi¢ed and its translocation from the inter-
membrane space (IMS) to the cytoplasm has been observed in
many models of apoptosis [2]. Another mitochondrial apop-
togenic factor was recently identi¢ed, the apoptosis-inducing
factor (AIF), which induces apoptotic changes such as chro-
matin condensation and exposure of phosphatidylserine in the
plasma membrane [3]. In some cell types, procaspases-2 and -9
are also con¢ned in the intermembrane space and are released
at the same time as cytochrome c and AIF [4].
Proteins of the mammalian Bcl-2 family are either anti-
apoptotic (such as Bcl-2 and Bcl-xL) or pro-apoptotic (such
as Bax and Bak). Cell death can be induced in yeast by ex-
pressing a pro-apoptotic member of this family [5,6]. More-
over, the expression of Bax in yeast cells triggers similar apop-
totic changes to those occurring in mammalian cells [7].
Mitochondria also seem to be involved in Bax-induced cell
death in yeast since, as in mammalian cells, a release of cyto-
chrome c is observed [8].
A central role for cytochrome c and AIF in the apoptotic
pathway has been highlighted by studies showing that injec-
tion of these two e¡ectors of cell death into the cytosol of
mammalian cells induced apoptosis [3,9]. In the mammalian
cytoplasm, cytochrome c associates with the monomeric apop-
totic protease activating factor-1 (Apaf-1). Subsequent hydro-
lysis of ATP/dATP promotes oligomerisation of Apaf-1. The
resultant multimeric complex, the apoptosome, recruits and
activates procaspase-9 [10,11]. Once activated by cleavage,
mature caspase-9 can then process procaspase-3, setting into
motion the terminal caspase cascade [12].
The mechanism of release of mitochondrial apoptogenic
factors is still unclear. Based on in vitro experiments, three
hypotheses have been proposed [13]. First, when mitochondria
are induced to swell, the release of IMS components occurs.
Evidence for this idea comes from the induction of the non-
speci¢c permeability transition pore which correlated with mi-
tochondrial matrix swelling. The consequent disruption of the
outer mitochondrial membrane led to the release of proteins
from the IMS such as cytochrome c [14,15]. Second, Bax itself
can form very large channels in planar lipid bilayers. Should
such channels form in the outer mitochondrial membrane,
then they might be large enough to permit passage of cyto-
chrome c [16]. Third, Bax has been shown to interact with the
voltage dependent anion channel (VDAC) and the adenine
nucleotide carrier (ANT) [17]. Since VDAC is essential for
cytochrome c release in both wild type and VDAC-de¢cient
yeast mitochondria [17], Bax could complex with VDAC and/
or ANT to form a channel for cytochrome c release [13].
The requirement for a speci¢c mechanism of cytochrome c
release can be questioned since, in addition to proteins that
have a speci¢c role in apoptosis (i.e. cytochrome c, AIF, pro-
caspases-2 and -9), other proteins from the IMS are also
translocated into the cytoplasm (e.g. adenylate kinase, sul¢te
oxidase) [18]. Based on in vitro studies, it has been proposed
that protein release involves a general alteration of the per-
meability of the outer mitochondrial membrane, both in
mammalian [15] and in yeast [19] cells. However, there is no
indication that in vivo, a generalised translocation into the
cytoplasm of IMS proteins takes place.
We have designed experiments to probe the mechanism of
the release of cytochrome c in vivo. We have generated a
fusion between cytochrome c and the green £uorescent protein
(GFP) and expressed this fusion in yeast cells null for the
expression of natural cytochrome c. This enables e⁄cient de-
livery of the fusion to mitochondria. Confocal laser scanning
microscopy (CLSM) and Western blotting techniques are used
to show that this cytochrome c^GFP fusion is not released
from mitochondria on expression of Bax in intact yeast
cells.
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2. Materials and methods
2.1. Plasmid construction and yeast strains
A DNA cassette encoding yeast cytochrome c (isoform 1, Cyc1p)
was ampli¢ed by polymerase chain reaction (PCR) and cloned into
the BglII and NotI sites of the yeast multicopy expression vector
pAS1N [20], to form pAS1N^Cyc1p. pAS1N^Cyc1p^GFP was con-
structed as follows. A second DNA cassette encoding Cyc1p was
ampli¢ed by PCR using oligonucleotide primers designed such that
nucleotides at the 3P end specifying the stop codon of cytochrome c
were removed. This cassette was then cloned into the BglII site of
pAS1N^GFP [20]. The correct orientation of the Cyc1p-encoding in-
sert relative to the promoter and GFP encoding sequence was checked
by PCR.
The expression vector pCM189 carrying the human bax gene under
the control of a tetracycline-regulatable promoter has been described
previously [21]. A DNA sequence encoding the c-myc epitope was
introduced at the 3P end of the bax gene [5].
The yeast strain B-06748 (MATa, his3, leu2, trp1, ura3, cyh2, cy-
c1: :lacZ, cyc7: :CYH2), null for the expression of both isoforms 1
and 7 of cytochrome c (Cyc1p and Cyc7p, respectively) was trans-
formed with the vector pAS1N^Cyc1p or pAS1N^Cyc1p^GFP. These
vectors carry the LEU2 gene as a selectable marker enabling the
selection of transformants on synthetic minimal medium (0.7% yeast
nitrogen base w/o amino acids (Difco), 2% glucose) (SD), supple-
mented with histidine, tryptophan and uracil (each at 0.1 mg/ml).
Cells carrying pAS1N^Cyc1p or pAS1N^Cyc1p^GFP were subse-
quently transformed with pCM189-bax (which carries the URA3 se-
lectable marker) and transformants were selected on minimal medium
supplemented with histidine and tryptophan.
2.2. Growth conditions and preparation of spheroplasts
Cells were pregrown in SD medium with relevant auxotrophic re-
quirements, containing doxycycline (1 Wg/ml) to prevent Bax expres-
sion [22]. The cells were then washed and 2U107 cells inoculated into
SaccE medium containing 2% ethanol as a carbon source [23] con-
taining auxotrophic requirements, in the presence (Bax-repressed) or
in the absence (Bax-induced) of doxycycline. The increase of turbidity
of cultures was followed using a Klett^Summerson photoelectric col-
orimeter.
Survival tests were performed as described [21].
For spheroplast preparation, cells were pregrown as above. Cells
were harvested, washed and inoculated into fresh SaccE medium ei-
ther with (Bax-repressed) or without (Bax-induced) doxycycline. Cells
were then allowed to grow overnight and harvested in the mid-log-
phase of growth. Spheroplasts were prepared according to Averet et
al. [24] with the modi¢cation that no bovine serum albumin (BSA)
was included in bu¡er S (1 M sorbitol, 2 mM MgSO4, 0.5 mM
EGTA, 10 mM K2HPO4, pH 6.8).
2.3. Permeabilisation of spheroplasts and protein analysis
Ten mg dry weight spheroplasts were suspended in 1 ml of bu¡er S.
After the addition of 0.25 mg nystatin (2.5 mg/ml in distilled water),
the suspension was incubated at 28‡C for various times. Spheroplasts
were then centrifuged in a microfuge for 3 min and the supernatant
and pellet separated. Pellets were suspended in 1 ml distilled water.
Proteins from the pellet and the supernatant were precipitated by the
addition of 0.1 ml 3 M trichloroacetic acid. After centrifugation,
proteins from the pellets were solubilised in 0.2 ml 5% sodium dodecyl
sulfate (SDS). Dissociation bu¡er (0.2 ml) was then added and 50 Wg
protein separated by electrophoresis on 15% SDS^polyacrylamide gel.
Proteins from the supernatants were solubilised in 50 Wl 5% SDS and
50 Wl dissociation bu¡er and 10 Wl portions electrophoresed as above.
Proteins were then transferred to Immobilon P membranes (Millipore,
MA, USA). Membranes were incubated with rabbit polyclonal anti-
bodies directed against cytochrome c diluted 1/2000 (kindly provided
by Dr F. Sherman, University of Rochester). Immunoblotting and
estimation of the intensity of the signals were performed as previously
described [25].
For whole cell lysates, yeast cells were lysed [26], and Western
analysis was carried out as described above, with antibodies directed
against cytochrome c. Bax expression was analysed [21] with mono-
clonal antibodies directed against the c-myc epitope diluted 1/500 (gift
from Dr C.A. Mitchell, Monash University).
Protein concentrations were determined according to Lowry et al.
[27] in the presence of 5% SDS. BSA was used as the standard pro-
tein.
2.4. Citrate synthase (CS) and glucose-6-phosphate dehydrogenase
(G6PDH) activities
The CS activity was measured according to Priault et al. [19]. The
G6PDH activity was measured as the formation of NADPH. An
aliquot of the samples (50 Wl) was added to 0.9 ml 50 mM triethanol-
amine/HCl bu¡er (pH 7.4) containing 3.75 mM EDTA, 7.5 mM
MgCl2 and 1 mM NADP. The absorbance was measured at 340 nm
in a Beckman DU7500 spectrophotometer (O= 6200 M31 cm31).
2.5. CLSM
Yeast cells were pregrown in SD medium and then cultured in
SaccE medium in the presence or absence of doxycycline as described
in Section 2.2. Cells were harvested in the mid-log phase, washed in
distilled water and air-dried onto the under-side of poly-L-lysine-
coated coverslips. CLSM images were generated using the Leica
TCS NT system (Leica Instruments, Australia), FITC ¢lter sets and
illumination with a 488 nm laser line [20].
3. Results and discussion
3.1. The cytochrome c^GFP fusion protein is functional
We found that cells with endogenous cytochrome c genes,
transformed with pAS1N^Cyc1p^GFP were unable to accu-
mulate the Cyc1p^GFP fusion e⁄ciently or speci¢cally in mi-
tochondria (data not shown). Therefore, to prevent expression
of any endogenous cytochrome c, cells null for the expression
of the two isoforms Cyc1p and Cyc7p were used in all experi-
ments reported here. Cells of strain B-06748 are unable to
grow on a non-fermentable substrate such as ethanol since
they lack a respiratory chain function. These cells were trans-
formed with expression vectors such that cells would express
either Cyc1p or Cyc1p^GFP, in each case combined with the
inducible expression of Bax. Transformants were selected on
appropriate medium containing glucose as a substrate (plus
doxycycline to prevent the expression of Bax). Growth of the
cells was then tested on ethanol-containing medium (Fig. 1).
In the presence of doxycycline, cells expressing Cyc1p^GFP
showed substantial growth, although the rate was slightly de-
creased relative to cells expressing Cyc1p (Fig. 1A,B, open
circles). The Cyc1p^GFP fusion is evidently able to function
as a mobile electron carrier between complexes III and IV of
the respiratory chain.
When cells were grown in the absence of doxycycline to
activate Bax expression, growth rates were reduced but not
fully abolished (Fig. 1A,B, closed circles), as has been previ-
ously observed by others [19]. This reduction in growth rate at
a population level was due to Bax-induced mortality. Indeed,
when aliquots of the cultures were diluted and plated to mea-
sure colony forming e⁄ciency on non-selective doxycycline-
containing plates, the number of colonies after Bax expression
was reduced by 60^70% in both cases (Fig. 1C,D). This result
suggested that the expression of Cyc1p^GFP did not modify
the ability of Bax to induce cell death.
Lysates from cells expressing Cyc1p and Cyc1p^GFP were
probed with polyclonal antibodies directed against Cyc1p
(Fig. 2). Cyc1p migrated with a mobility corresponding to
its size of 14 kDa (Fig. 2, lane 1). The size of the correspond-
ing immunodetected band in lysates from cells expressing
Cyc1p^GFP was about 45 kDa (Fig. 2, lane 3), which is con-
sistent with that expected (14 kDa for Cyc1p plus 27 kDa for
GFP). Signi¢cantly, no free cytochrome c was detected in this
experiment, suggesting that the majority of the fusion Cyc1p^
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GFP remained intact after expression and import into the
mitochondria. It is therefore unlikely that there would be
enough free Cyc1p to sustain the growth of these cells on
ethanol. Using antibodies speci¢c for GFP, some free GFP
was detected at 27 kDa (not shown), consistent with the very
stable nature of GFP, highly resistant to protease degrada-
tion. Expression of Bax did not modify the expression of
Cyc1p and Cyc1p^GFP (Fig. 2, lanes 2 and 4, respectively).
Therefore, any e¡ect of Bax cannot be attributed to an indi-
rect e¡ect on the level of cytochrome c in the cells.
The cellular distribution of Cyc1p^GFP was imaged using
CLSM. The £uorescence displayed a ¢lamentous array (Fig.
3A), consistent with a location within the mitochondria [20].
When cells were loaded with MitoTracker Red (CMXRos)
which localises to mitochondria [28], GFP £uorescence dis-
played the same pattern as MitoTracker Red £uorescence
(not shown). Taken together, these results showed that
Cyc1p^GFP is a functional electron carrier and could be cor-
rectly imported into, and localised within, the mitochondrial
IMS.
3.2. The cytochrome c^GFP fusion is not released upon
expression of Bax
Cells were grown in the presence of doxycycline to repress
Bax expression. Spheroplasts were prepared and the plasma
membrane permeabilised with nystatin for various times as
described in Section 2. In the ¢rst instance, permeabilisation
of the plasma membrane with nystatin was calibrated using
two enzyme markers: G6PDH, a cytosolic enzyme, and CS, a
mitochondrial matrix enzyme. As shown in Fig. 4A, G6PDH
activity was detected in the supernatant of spheroplasts after
5 min permeabilisation with nystatin. No CS activity was
present in the supernatant. After 14 min incubation with nys-
tatin, intracellular membranes, such as mitochondrial mem-
branes, were also permeabilised and CS activity in the super-
natant increased substantially (Fig. 4A). On the basis of these
results, cytochrome c present in the cytosol should be detected
in the supernatant fraction prepared from spheroplasts per-
meabilised for 5 min with nystatin.
Cyc1p and Cyc1p^GFP were detected in the pellet fraction
of non-permeabilised spheroplasts, whether or not Bax was
expressed (Fig. 4B, compare lanes 1 and 7). Cytochrome c
was barely detectable in the corresponding supernatants
(Fig. 4B, lanes 2 and 8). When the experiment was repeated
with permeabilised spheroplasts prepared from cells grown in
Fig. 1. Bax-induced cell lethality. A and C: Cells expressing Cyc1p. B and D: Cells expressing Cyc1p^GFP. Cultures were grown in the pres-
ence (open circles) or absence (closed circles) of doxycycline (see A and B). When the turbidity reached 400 Klett units, an aliquot of each cul-
ture was taken, diluted and spread at about 100 cells/plate on solid complete glucose medium in the presence of doxycycline. C and D: Plates
from the (+doxycycline) culture (3Bax) and the (3doxycycline) culture (+Bax). C: (3Bax), 81 cells ; (+Bax), 33 cells. D: (3Bax), 94 cells ;
(+Bax), 36 cells.
Fig. 2. Cyc1p and Cyc1p^GFP expression. Cell lysates were pre-
pared as described in Section 2 and 50 Wg of proteins were sepa-
rated in a 15% polyacrylamide gel. After transfer, membranes were
probed with polyclonal antibodies against cytochrome c. Lanes 1
and 3: lysates from cells expressing Cyc1p or Cyc1p^GFP, respec-
tively, grown in the absence (3) of Bax expression. Lanes 2 and 4:
lysates from cells expressing Cyc1p or Cyc1p^GFP, respectively,
grown in the presence (+) of Bax expression. Molecular weight
standards are indicated on the left side in kDa. Arrows indicate the
position of Cyc1p (lanes 1^2) and Cyc1p^GFP (lanes 3^4).
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the presence of doxycycline (Bax-repressed), Cyc1p and
Cyc1p^GFP were associated with the pellet fraction (Fig.
4B, lane 3). No cytochrome c was detected in the correspond-
ing supernatant fraction (Fig. 4B, lane 4). When the cells were
grown in the absence of doxycycline (Bax-induced), Cyc1p
was detected both in the pellet and supernatant fractions of
permeabilised spheroplasts (Fig. 4B, lanes 9 and 10), indicat-
ing a release of Cyc1p into the cytoplasm. Surprisingly,
Cyc1p^GFP was not detected in the supernatant (Fig. 4B,
lane 10). It was concluded that Cyc1p^GFP was not released
in the cytoplasm upon expression of Bax. When permeabilisa-
tion of the plasma membrane was conducted for 14 min, the
integrity of mitochondrial membranes within cells was lost (as
shown by the presence of CS in the supernatant fractions, Fig.
4A) and release of Cyc1p or Cyc1p^GFP was observed
whether or not Bax was expressed (Fig. 4B, compare lanes 5
and 6 with 11 and 12).
After permeabilisation with nystatin for various times, the
presence of cytochrome c in the supernatant was probed in
parallel with that of G6PDH and CS. Release of Cyc1p oc-
curred at the same time as that of G6PDH (Fig. 4C). In
contrast, release of Cyc1p^GFP paralleled that of CS (Fig.
4C). These results de¢nitively con¢rmed that Cyc1p was re-
leased in the cytosol upon expression of Bax, but not Cyc1p^
GFP.
Cells expressing Cyc1p^GFP were grown in the presence or
absence of doxycycline and imaged by CLSM (Fig. 3). Under
Bax-repressed conditions, the £uorescence was clearly associ-
ated with the mitochondria only (Fig. 3A) (see Section 3.1).
Under Bax-induced conditions, Cyc1p^GFP £uorescence dis-
played the same pattern (Fig. 3B); no £uorescence could be
observed in the cytoplasm, con¢rming the results shown in
Fig. 4. The expression of Bax was con¢rmed by immunoblot
(Fig. 3A,B, inset).
3.3. Conclusions
We have engineered in yeast, a non-releasable form of cy-
tochrome c. The morphology of mitochondria, as judged by
Fig. 3. CLSM images of cells expressing Cyc1p^GFP under conditions of the absence (A) or presence of Bax expression (B). Inset in each pan-
el: expression of Bax (arrowed) was detected in cell lysates by Western blotting. Positions of molecular weight standards are indicated at the
right (kDa).
C
Fig. 4. Bax-induced cytochrome c release in permeabilised sphero-
plasts. Cells expressing Cyc1p or Cyc1p^GFP were grown in SaccE
medium, until the mid-log phase in the presence (3Bax) or the ab-
sence (+Bax) of doxycycline. Spheroplast preparation and permeabi-
lisation were performed as described in Section 2. A: CS (E) and
G6PDH (F) activities were measured on non-permeabilised and per-
meabilised spheroplasts. Results are expressed as percentage of en-
zyme activity found in the supernatant before (0 min) or after (5 or
14 min) permeabilisation. B: Proteins from the pellet fraction (odd
numbered lanes) and the supernatant fraction (even numbered lanes)
were separated in a 15% SDS^polyacrylamide gel, transferred to Im-
mobilon membrane and probed with cytochrome c polyclonal anti-
bodies. The absence (3Bax) or presence (+Bax) of expression of
Bax is indicated, together with the times of nystatin treatment (min)
to permeabilise spheroplasts. C: Release of G6PDH (b), CS (a),
Cyc1p (F) and Cyc1p^GFP (E) was assessed after permeabilisation
of spheroplasts for various times. Results are expressed as percent-
age of CS and G6PDH activity in the supernatant, or intensity of
chemi£uorescence signal for Cyc1p and Cyc1p^GFP detected in the
supernatant. 100% activity was 18 þ 2 nmol min31 mg31 protein
and 46 þ 5 nmol min31 mg31 protein for CS and G6PDH, respec-
tively (A and C). Similar results were obtained in three other inde-
pendent spheroplast preparations.
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the £uorescence of GFP in the IMS, was not modi¢ed after
Bax expression. This con¢rmed previous observations based
on electron microscopy images of Bax-expressing yeasts [21].
The absence of gross alteration in mitochondrial distribution
or morphology in cells expressing Bax suggests that such
changes were not responsible for the non-release of Cyc1p^
GFP. Moreover, despite the absence of translocation of
Cyc1p^GFP into the cytosol, the expression of Bax still in-
duced cell death. There are two main conclusions arising from
these results.
First, the release of cytochrome c is not required for Bax-
induced cell death to occur in yeast cells. It was shown that in
cells unable to express cytochrome c, Bax-induced lethality
was not prevented [21]. However, the only source of energy
for the growth of those cells deprived of cytochrome c due to
gene knockout is from glycolysis. It could be argued that
cytochrome c is not essential for Bax-induced lethality under
fermentative (but not respiratory) conditions. Here, we show
that even under respiratory conditions, the release and the
presence of cytochrome c in the cytoplasm is not essential
for Bax-induced cell death in yeast. Bcl-2 proteins regulate
cytochrome c release both in mammalian [13] and yeast [19]
cells. However, contrary to mammalian cells, yeast do not
express caspases, which could explain why the presence of
cytochrome c in the yeast cytoplasm is not essential for cell
death.
Second, these results suggest that in vivo, Bax does not
induce a non-speci¢c rupture of the mitochondrial outer mem-
brane and a concomitant release of any proteins of the IMS.
Indeed, GFP has been shown to di¡use freely in the cyto-
plasm and in intracellular organelles [29]. Thus, it is unlikely
that GFP would prevent the di¡usion of cytochrome c into
the cytoplasm upon disruption of the outer membrane. There
are two main reasons why Cyc1p^GFP might not show re-
lease. Either the protein fusion is too big to permit passage
through a pore or the C-terminal domain of Cyc1p to which
GFP is fused must be free for cytochrome c to be released.
However, the presence of a hexahistidine tag at the C-termi-
nus of Cyc1p did not prevent its release induced by Bax (not
shown). It is, therefore, more likely that Cyc1p^GFP is not
translocated in the cytoplasm because of its size. If so, it
provides evidence in support of the translocation of cyto-
chrome c through a channel, as proposed by some authors
[30]. Indeed, in order for the assembly of the apoptosome to
be e⁄cient, one may consider that the release of cytochrome c
would be regulated both in time and in space and, therefore,
occurs by a speci¢c mechanism.
Release of a cytochrome c^GFP fusion was observed in
mammalian cells [31]. However, in this study, apoptosis was
induced by staurosporine. Therefore, either the mechanism of
the release of cytochrome c is di¡erent in mammalian cells
from yeast cells or the mechanism varies according to the
apoptosis inducer.
The possibility of engineering non-releasable forms of cyto-
chrome c in yeast opens a new avenue for the elucidation of
the mechanism of cytochrome c release during cell death. It
would now be important to de¢ne size limits for release and
the nature of the release apparatus.
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